European Companies Search Engine
EU funding (€6,000,000): Pharmacogenomic Biomarkers as Clinical Decision Making Tools for Clozapine Treatment of Schizophrenia Fts1 Nov 2011 Financial Transparency System
Overview
Text
This publication is not available.
The filing refers to a past date, and does not necessarily reflect the current state.